Advanced search
1 file | 1.11 MB Add to list

Quality indicators in neuro-oncology : review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey

(2022) JOURNAL OF NEURO-ONCOLOGY. 157(2). p.365-376
Author
Organization
Abstract
Background Quality Indicators (QIs) are important tools to assess the quality and variability of oncological care. However, their application in neuro-oncology is limited so far. The objective of this study was to develop a set of QIs for glioma, covering process and outcome indicators. Methods A systematic review was conducted to identify both QIs in the field of adult glioma care, and guidelines or recommendations that could be translated into QIs. Also reports from national and international healthcare agencies and scientific associations ("grey literature") were taken into account. After conversion of these recommendations into QIs, merging with existing QIs found in the literature and rationalization, a two-round Delphi survey was conducted to gain consensus on relevance for the proposed QIs. Results In total 240 recommendations and 30 QIs were retrieved from the literature. After conversion, merging and rationalization, 147 QIs were evaluated in the Delphi survey and eventually consensus was gained on 47 QIs in the following 7 domains: Diagnosis and Imaging, Surgery, Pathology, Radio/Chemotherapy, Recurrence, Supportive Treatments (Epilepsy, Thromboembolism, Steroid Use and Rehabilitation) and Survival. Conclusion This study defined a set of 47 QIs for assessing quality of care in adult glioma patients, distributed amongst 7 crucial phases in the patient's care trajectory. These QIs are readily applicable for use in diverse health care systems, depending on the availability of population-based health care data enabling (inter)national benchmarking.
Keywords
Cancer Research, Neurology (clinical), Neurology, Oncology, Glioma, Quality indicators, Delphi, Outcome, Quality assessment, Benchmarking, CENTRAL-NERVOUS-SYSTEM, GUIDELINES, DIAGNOSIS, CLASSIFICATION, TUMORS, PET

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.11 MB

Citation

Please use this url to cite or link to this publication:

MLA
Vanhauwaert, Dimitri, et al. “Quality Indicators in Neuro-Oncology : Review of the Literature and Development of a New Quality Indicator Set for Glioma Care through a Two-Round Delphi Survey.” JOURNAL OF NEURO-ONCOLOGY, vol. 157, no. 2, 2022, pp. 365–76, doi:10.1007/s11060-022-03971-3.
APA
Vanhauwaert, D., Pinson, H., Sweldens, C., Du Four, S., Van Eycken, L., De Schutter, H., … QINO consortium, [missing]. (2022). Quality indicators in neuro-oncology : review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey. JOURNAL OF NEURO-ONCOLOGY, 157(2), 365–376. https://doi.org/10.1007/s11060-022-03971-3
Chicago author-date
Vanhauwaert, Dimitri, Harry Pinson, Caroline Sweldens, Stephanie Du Four, Liesbet Van Eycken, Harlinde De Schutter, Steven De Vleeschouwer, Tom Boterberg, and [missing] QINO consortium. 2022. “Quality Indicators in Neuro-Oncology : Review of the Literature and Development of a New Quality Indicator Set for Glioma Care through a Two-Round Delphi Survey.” JOURNAL OF NEURO-ONCOLOGY 157 (2): 365–76. https://doi.org/10.1007/s11060-022-03971-3.
Chicago author-date (all authors)
Vanhauwaert, Dimitri, Harry Pinson, Caroline Sweldens, Stephanie Du Four, Liesbet Van Eycken, Harlinde De Schutter, Steven De Vleeschouwer, Tom Boterberg, and [missing] QINO consortium. 2022. “Quality Indicators in Neuro-Oncology : Review of the Literature and Development of a New Quality Indicator Set for Glioma Care through a Two-Round Delphi Survey.” JOURNAL OF NEURO-ONCOLOGY 157 (2): 365–376. doi:10.1007/s11060-022-03971-3.
Vancouver
1.
Vanhauwaert D, Pinson H, Sweldens C, Du Four S, Van Eycken L, De Schutter H, et al. Quality indicators in neuro-oncology : review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey. JOURNAL OF NEURO-ONCOLOGY. 2022;157(2):365–76.
IEEE
[1]
D. Vanhauwaert et al., “Quality indicators in neuro-oncology : review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey,” JOURNAL OF NEURO-ONCOLOGY, vol. 157, no. 2, pp. 365–376, 2022.
@article{8745230,
  abstract     = {{Background Quality Indicators (QIs) are important tools to assess the quality and variability of oncological care. However, their application in neuro-oncology is limited so far. The objective of this study was to develop a set of QIs for glioma, covering process and outcome indicators. Methods A systematic review was conducted to identify both QIs in the field of adult glioma care, and guidelines or recommendations that could be translated into QIs. Also reports from national and international healthcare agencies and scientific associations ("grey literature") were taken into account. After conversion of these recommendations into QIs, merging with existing QIs found in the literature and rationalization, a two-round Delphi survey was conducted to gain consensus on relevance for the proposed QIs. Results In total 240 recommendations and 30 QIs were retrieved from the literature. After conversion, merging and rationalization, 147 QIs were evaluated in the Delphi survey and eventually consensus was gained on 47 QIs in the following 7 domains: Diagnosis and Imaging, Surgery, Pathology, Radio/Chemotherapy, Recurrence, Supportive Treatments (Epilepsy, Thromboembolism, Steroid Use and Rehabilitation) and Survival. Conclusion This study defined a set of 47 QIs for assessing quality of care in adult glioma patients, distributed amongst 7 crucial phases in the patient's care trajectory. These QIs are readily applicable for use in diverse health care systems, depending on the availability of population-based health care data enabling (inter)national benchmarking.}},
  author       = {{Vanhauwaert, Dimitri and Pinson, Harry and Sweldens, Caroline and Du Four, Stephanie and Van Eycken, Liesbet and De Schutter, Harlinde and De Vleeschouwer, Steven and Boterberg, Tom and QINO consortium, [missing]}},
  issn         = {{0167-594X}},
  journal      = {{JOURNAL OF NEURO-ONCOLOGY}},
  keywords     = {{Cancer Research,Neurology (clinical),Neurology,Oncology,Glioma,Quality indicators,Delphi,Outcome,Quality assessment,Benchmarking,CENTRAL-NERVOUS-SYSTEM,GUIDELINES,DIAGNOSIS,CLASSIFICATION,TUMORS,PET}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{365--376}},
  title        = {{Quality indicators in neuro-oncology : review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey}},
  url          = {{http://doi.org/10.1007/s11060-022-03971-3}},
  volume       = {{157}},
  year         = {{2022}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: